Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

UEG Week 2016 Poster Presentations

United European Gastroenterology Journal (2016) Vol. 4, Iss. 5_suppl, pp. A157-A720
Open Access | Times Cited: 23

Showing 23 citing articles:

Rifaximin for prevention and treatment of hepatic encephalopathy in people with cirrhosis
Harry D Zacharias, Fady Kamel, Jaclyn Tan, et al.
Cochrane library (2023) Vol. 2023, Iss. 7
Closed Access | Times Cited: 23
Comparative study of probiotic effects of Lactobacillus and Bifidobacteria strains on cholesterol levels, liver morphology and the gut microbiota in obese mice
Rostyslav Bubnov, Л. П. Бабенко, Л. М. Лазаренко, et al.
The EPMA Journal (2017) Vol. 8, Iss. 4, pp. 357-376
Open Access | Times Cited: 87
Systematic review and meta‐analysis: assessment of factors affecting disability in inflammatory bowel disease and the reliability of the inflammatory bowel disease disability index
Bobby Lo, Michelle V. Prosberg, Lise Lotte Gluud, et al.
Alimentary Pharmacology & Therapeutics (2017) Vol. 47, Iss. 1, pp. 6-15
Open Access | Times Cited: 52
Can tailored nanoceria act as a prebiotic? Report on improved lipid profile and gut microbiota in obese mice
Rostyslav Bubnov, Л. П. Бабенко, Л. М. Лазаренко, et al.
The EPMA Journal (2019) Vol. 10, Iss. 4, pp. 317-335
Open Access | Times Cited: 51
An update on efficacy and safety considerations for the latest drugs used to treat irritable bowel syndrome
Taraneh Mousavi, Shekoufeh Nikfar, Mohammad Abdollahi
Expert Opinion on Drug Metabolism & Toxicology (2020) Vol. 16, Iss. 7, pp. 583-604
Closed Access | Times Cited: 24
New Alternative? Self-Assembling Peptide in Gastrointestinal Bleeding: A Systematic Review and Meta-Analysis
Banreet Singh Dhindsa, Kyaw Min Tun, Kyle Scholten, et al.
Digestive Diseases and Sciences (2023) Vol. 68, Iss. 9, pp. 3694-3701
Closed Access | Times Cited: 8
Small Bowel Motility
Carolina Malagelada, Juan R. Malagelada
Current Gastroenterology Reports (2017) Vol. 19, Iss. 6
Closed Access | Times Cited: 23
Prospects of polyglycolic acid sheets for the treatment of esophageal stricture after esophageal endoscopic submucosal dissection
Qingxia Wang, Ruihua Shi
World Journal of Gastrointestinal Endoscopy (2024) Vol. 16, Iss. 1, pp. 1-4
Open Access | Times Cited: 1
Acute Colonic Pseudo-Obstruction After Posterior Spinal Fusion: A Case Report and Literature Review
M. Usman Ahmad, Keyan D. Riley, Thomas Ridder
World Neurosurgery (2020) Vol. 142, pp. 352-363
Closed Access | Times Cited: 4
Serum Neutrophil Biomarkers to Predict Crohn's Disease Progression and Infliximab Treatment Outcomes
D. Magalhães, María José Santiago, Marta Patita, et al.
United European Gastroenterology Journal (2024)
Open Access
Fiducial Placement for Guidance of Radiotherapy
Irina M. Cazacu, Joseph M. Herman, Manoop S. Bhutani
Springer eBooks (2020), pp. 193-207
Closed Access | Times Cited: 2
Clinicopathological and prognostic features of colorectal mucinous adenocarcinomas: a systematic review and meta-analysis
Xiao Wang, Haoran Wang, Haoqing He, et al.
Research Square (Research Square) (2023)
Open Access
BIOLOGICAL THERAPY IN ADULT PATIENTS WITH ULCERATIVE COLITIS AND CROHN’S DISEASE: BUDGET IMPACT ANALYSIS
E. Pyadushkina
FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology (2017) Vol. 10, Iss. 1, pp. 19-28
Open Access
Azathioprine

Reactions Weekly (2018) Vol. 1684, Iss. 1, pp. 49-49
Closed Access
Multiple drugs with ciclosporin toxicity

Reactions Weekly (2018) Vol. 1684, Iss. 1, pp. 181-181
Closed Access
Infliximab

Reactions Weekly (2018) Vol. 1684, Iss. 1, pp. 133-133
Closed Access
Heparin

Reactions Weekly (2018) Vol. 1684, Iss. 1, pp. 116-116
Closed Access
Influenza virus vaccine

Reactions Weekly (2018) Vol. 1684, Iss. 1, pp. 135-135
Closed Access
Multiple drugs

Reactions Weekly (2018) Vol. 1684, Iss. 1, pp. 174-174
Closed Access
Economic rationale for administration of vedolizumab in patients with inflammatory bowel disease in Moscow
Ekaterina B. Kornilova, K. I. Polyakova, Т. В. Шкурко, et al.
Russian Journal of Evidence-Based Gastroenterology (2019) Vol. 8, Iss. 3, pp. 55-55
Closed Access
Meta-analysis of vonoprazan and proton pump inhibitors in preventing delayed bleeding and facilitating ulcer healing after gastric endoscopic submucosal dissection
Xuan Chen, Mengting Xu, Jianbo Wen
Shijie huaren xiaohua zazhi (2020) Vol. 28, Iss. 24, pp. 1249-1260
Open Access
Comparing outcomes from tailored meta-analysis with outcomes from a setting specific test accuracy study using routine data of faecal calprotectin testing for inflammatory bowel disease
Karoline Freeman, Brian H Willis, Ronan Ryan, et al.
BMC Medical Research Methodology (2022) Vol. 22, Iss. 1
Open Access
Key success factors for lean six sigma implementation on Light Rail Transit Station construction project
Ulfa Soraya, Albert Eddy Husin, Bernadette Detty Kussumardianadewi, et al.
Teknika Jurnal Sains dan Teknologi (2022) Vol. 18, Iss. 1, pp. 56-56
Open Access
Page 1

Scroll to top